$52.49-$0.44 (-0.83%)
iShares International Developed Small Cap Value Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 5.36% below the high.
NASDAQ · GEME · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Pacific NoS Global EM Equity Active ETF’s quoted price sits in the lower half of its reported 52-week range, 18.59% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The GEME fund aims to capture the significant growth potential of emerging markets through a concentrated investment approach, typically holding between 20 and 50 distinct equity and equity-linked securities. Its portfolio includes common and preferred stocks, along with American Depositary Receipts (ADRs), sourced from both large- and mid-capitalization companies. The fund commits a minimum of 40% of its assets to a diverse range of non-U.S. countries, reducing this allocation to no less than 30% under less favorable market conditions. Its investment philosophy is value-driven, meticulously identifying and acquiring undervalued companies believed to be trading below their true worth. This is accomplished using proprietary valuation models that synthesize a top-down assessment of macroeconomic trends with a rigorous bottom-up analysis of individual companies. While primarily focused on equities, the fund may also allocate up to 10% of its assets to fixed-income securities, participatory notes for accessing restricted markets, and China A-shares. To mitigate currency risk, derivatives are employed for hedging. The fund is authorized to use leverage, up to 15% for long positions, and may establish short positions, capped at 20%, strictly for hedging purposes. Investments are liquidated when they either exceed their estimated intrinsic value, exhibit a decline in fundamental business strength, or heighten the overall risk profile of the portfolio.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 05:40 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$52.49-$0.44 (-0.83%)
iShares International Developed Small Cap Value Factor ETF’s quoted price sits in the upper half of its reported 52-week range, 5.36% below the high.
$33.23+$0.09 (+0.29%)
GMO US Value ETF’s quoted price sits in the upper half of its reported 52-week range, 0.73% below the high.
$44.88-$0.78 (-1.72%)
Affinity World Leaders Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 8.68% below the high.
$34.92+$2.43 (+7.48%)
WBI Power Factor High Dividend ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$37.56-$0.57 (-1.49%)
Lazard Japanese Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 6.06% below the high.
$32.79-$0.94 (-2.8%)
Emerging Markets Equity ETF’s quoted price sits in the lower half of its reported 52-week range, 15.96% below the high.
$39.38-$0.19 (-0.48%)
Xtrackers FTSE Developed ex US Multifactor ETF’s quoted price sits in the upper half of its reported 52-week range, 4.24% below the high.
$69.31+$1.34 (+1.97%)
Invesco KBW Regional Banking ETF’s quoted price sits in the upper half of its reported 52-week range, 5.04% below the high.